BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 28774304)

  • 1. Using omics approaches to understand pulmonary diseases.
    Kan M; Shumyatcher M; Himes BE
    Respir Res; 2017 Aug; 18(1):149. PubMed ID: 28774304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Holistic Integration of Omics Tools for Precision Nutrition in Health and Disease.
    Ramos-Lopez O; Martinez JA; Milagro FI
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Omics to Characterize and Classify Pulmonary Vascular Disease.
    Leopold JA; Hemnes AR
    Clin Chest Med; 2021 Mar; 42(1):195-205. PubMed ID: 33541613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data analysis methods for defining biomarkers from omics data.
    Li C; Gao Z; Su B; Xu G; Lin X
    Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics study for interpretation of genome-wide association study.
    Akiyama M
    J Hum Genet; 2021 Jan; 66(1):3-10. PubMed ID: 32948838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 10. Role of high dimensional technology in preeclampsia (omics in preeclampsia).
    Youssef L; Testa L; Crovetto F; Crispi F
    Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102427. PubMed ID: 37995432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics technologies in allergy and asthma research: An EAACI position paper.
    Radzikowska U; Baerenfaller K; Cornejo-Garcia JA; Karaaslan C; Barletta E; Sarac BE; Zhakparov D; Villaseñor A; Eguiluz-Gracia I; Mayorga C; Sokolowska M; Barbas C; Barber D; Ollert M; Chivato T; Agache I; Escribese MM
    Allergy; 2022 Oct; 77(10):2888-2908. PubMed ID: 35713644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Cell Identity with Single-Cell Omics.
    Mincarelli L; Lister A; Lipscombe J; Macaulay IC
    Proteomics; 2018 Sep; 18(18):e1700312. PubMed ID: 29644800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From flesh to bones: Multi-omics approaches in forensic science.
    Procopio N; Bonicelli A
    Proteomics; 2024 Jun; 24(12-13):e2200335. PubMed ID: 38683823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrosis: Lessons from OMICS analyses of the human lung.
    Yu G; Ibarra GH; Kaminski N
    Matrix Biol; 2018 Aug; 68-69():422-434. PubMed ID: 29567123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Omics Analyses Enabled by Microchip Technologies.
    Deng Y; Finck A; Fan R
    Annu Rev Biomed Eng; 2019 Jun; 21():365-393. PubMed ID: 30883211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating omics technologies to study pulmonary physiology and pathology at the systems level.
    Pathak RR; Davé V
    Cell Physiol Biochem; 2014; 33(5):1239-60. PubMed ID: 24802001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systems medicine of neonatal abstinence syndrome.
    Stone WL; Wood DL; Justice NA; Shah DS; Olsen ME; Bharti D
    Front Biosci (Landmark Ed); 2020 Jan; 25(4):736-759. PubMed ID: 31585915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multi-omics technology and its applications to life sciences: a review].
    Liu J; Li W; Wang L; Li J; Li E; Luo Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3581-3593. PubMed ID: 36305394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinician's guide to omics resources in dermatology.
    Doolan BJ; McGrath JA; Onoufriadis A
    Clin Exp Dermatol; 2022 May; 47(5):858-866. PubMed ID: 35104371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
    Chadha M; Huang PH
    Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
    Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
    Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.